Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
04/2006
04/26/2006CN1762355A (imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation
04/26/2006CN1253451C Novel indodyl oxazole compound and its preparation and application
04/26/2006CN1253450C Method of mycophenolate mofetil preparation
04/26/2006CN1253442C Novel thiazine or pyrazine derivatives
04/26/2006CN1253441C Protease inhibitors
04/25/2006US7034110 Method of identifying chemical compounds having selected properties for a particular application
04/25/2006US7034057 Controlling tumor necrosis factor; antiinflamamtory agents, autoimmune disease
04/25/2006US7034056 Aryl and biaryl compounds having MCH modulatory activity
04/25/2006US7034051 Fused bicyclic carboxamide derivatives and methods of their use
04/25/2006US7034049 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents
04/25/2006US7034048 Gastrin and cholecystokinin receptor ligands (III)
04/25/2006US7034047 Triazole derivative
04/25/2006US7034039 Fused heterocyclic compounds
04/25/2006US7034035 Having a high residual activity, greater activity at lower application rates, curative activity, and a broader spectrum of efficacy; heterocyclic aromatic amides having a hydroxy group adjacent to the amide functionality
04/25/2006US7034022 Proteases, kinases enzyme inhibitors; cardiovascular disorders; central nervous system disorders; antiinflammatrory agents; bone disorders; infections
04/25/2006US7034021 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
04/25/2006US7034017 Substituted oxazolidinones and their use in the field of blood coagulation
04/25/2006CA2167291C Substituted 2-phenylpyridines with herbicidal action
04/20/2006WO2006041872A2 Thrombin receptor antagonists
04/20/2006WO2006041635A2 Arylthiobenzylpiperidine derivatives
04/20/2006WO2006041405A1 Substituted amino-pyrimidones and uses thereof
04/20/2006WO2006041056A1 Metal-containing coordination compound, coordination compound residue-containing polymer compound, organic electroluminescent material, white organic electroluminescent material, white light-emitting device, and light-emitting device
04/20/2006WO2006040646A1 Benzimidazole or indole amides as inhibitors of pin1
04/20/2006WO2006040614A1 Substituted oxazolidinone derivatives
04/20/2006WO2006040182A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
04/20/2006WO2006040056A1 Heterocyclic substituted bisarylurea derivatives as kinase inhibitors
04/20/2006WO2006025979A9 Modulators of nuclear receptors
04/20/2006WO2006021002A3 Compounds useful for inhibiting chk1
04/20/2006WO2005115398A3 Hiv integrase inhibitors
04/20/2006WO2005094514A3 Heteroaryl piperidine glycine transporter inhibitors
04/20/2006US20060084810 Antibacterial 1,3-oxazolidin-2-one derivatives
04/20/2006US20060084809 Compounds as PDE IV and TNF-inhibitors
04/20/2006US20060084802 Modulate function of peroxisome proliferator-activated receptors (PPAR) gamma or PPAR delta; diabetes, obesity, hypercholesterolemia, rheumatoid arthritis and atherosclerosis; 2-Amino-5-bromo-isonicotinic acid methyl and ethyl esters; 2-amino-5-iodo-isonicotinic acid pentyl ester
04/20/2006US20060084690 Isoxazole derivatives
04/20/2006US20060084688 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
04/20/2006US20060084687 N-(3-aminopropyl)-N-[(1R)-1-(1-benzyl-1H-benzimidazol-2-yl)-2-methylpropyl]-4-chlorobenzamide;kinesin spindle protein modulators; anticarcinogenic agents; in vivo stability, bio-availability; diagnosis/medical/;antitumor agents hyperplasia; restinosis; antiinflammatory agents; cardiac hypertrophy
04/20/2006US20060084681 Substituted pyrazoles, compositions containing such compounds and methods of use
04/20/2006US20060084663 Alkanoic acids, nitriles and amides substituted with a group containing benzene ring linked through a thiazolyl- or oxazolyl- phenyl group; e.g., {4-[4-Methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl]-2-propyl-phenoxy}-acetic acid; treating diabetes and atherosclerosis
04/20/2006US20060084658 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound
04/20/2006US20060084651 Chemical compounds
04/20/2006US20060084648 Ethynyl derivatives as factor xa inhibitors
04/20/2006US20060084647 Small molecule inhibitors of anti-apoptotic BCL-2 family members and the uses thereof
04/20/2006US20060084645 Novel pyrimidine compounds, process for their preparation and compositions containing them
04/20/2006US20060084644 Atherosclerosis, unwanted cellular growth or cellular proliferation, diabetes, inflammatory conditions and vascular occlusive pathologic conditions; novel compound 1-[4-(4-Hydroxy-6'-phenyl-3,4,5,6-tetrahydro-2H-[1,4']bipyridinyl-2'-ylamino)-phenyl]-ethanone; modulation of glycosidase enzymes
04/20/2006US20060083676 For marking and identifying metabotropic glutamate receptor sites and for imaging an organ; in particular non-competitive mGlu1 receptor ligands
04/20/2006CA2793025A1 Fungicidal active ingredient combinations comprising fluoxastrobin and imidazole fungicides
04/20/2006CA2584185A1 Heterocyclic substituted bisarylurea derivates as kinase inhibitors
04/20/2006CA2583983A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
04/20/2006CA2583302A1 Novel oxadiazinone derivatives and use thereof as ppar-alpha modulators
04/20/2006CA2582639A1 Thrombin receptor antagonists
04/19/2006EP1646875A2 Method for characterising polypeptides by maldi-tof mass spectrometry
04/19/2006EP1646630A1 Oxazolidinone antibiotics and derivatives thereof
04/19/2006EP1646629A2 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
04/19/2006EP1646628A1 Benzenesulfonylamino compounds and pharmaceutical compositions containing these compounds
04/19/2006EP1646626A1 Pyrrole-2, 5-dione derivatives as liver x receptor modulators
04/19/2006EP1646620A1 Substituted piperidines as histamine h3 receptor ligands
04/19/2006EP1646615A1 Pyrimidine derivatives as modulators of atp-binding cassette transporters
04/19/2006EP1646613A1 Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors
04/19/2006EP1646382A2 Compounds, compositions and methods
04/19/2006EP1487801B1 7-arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo¬d|azepine derivatives with 5-ht6 receptor affinity for the treatment of cns disorders
04/19/2006EP1423363B1 Oral antidiabetic agents
04/19/2006EP1420784B1 Compounds effecting glucokinase
04/19/2006EP1349833B1 Indole and dihydroindole derivatives
04/19/2006EP1196167B1 Use of p38 MAPK inhibitors in the treatment of ophthalmic conditions
04/19/2006EP1189890B1 Dihydrobenzodiazepins and their use for treating dyslipidemia
04/19/2006EP1177176B1 Tri-aryl acid derivatives as ppar receptor ligands
04/19/2006EP1044197B1 Piperidinyl-substituted pyridylalkane, alkene and alkyne carboxamides as cytostatic agents and immunosuppressants
04/19/2006EP0901474B1 Aryl pyrimidine derivatives
04/19/2006EP0885215B1 Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
04/19/2006CN1761663A New heterocyclic compounds, a process for their preparation and their use as dyes and pigments
04/19/2006CN1761657A EP4 receptor antagonists
04/19/2006CN1761652A Cathepsin S inhibitors
04/19/2006CN1760194A Method for synthesizing 3-(5'-substitution-2-benzoxazole group)-7-diethyl amino group H-1-benzopyrans-2-ketone
04/19/2006CN1252067C Benzazole derivatives and their use as JNK modulators
04/19/2006CN1252066C Pyridazine-3-one derivatives, their use, and intermediate preparing them
04/18/2006US7030150 Benzimidazole compounds and antiviral uses thereof
04/18/2006US7030148 Heterocyclic compounds having antibacterial activity: process for their preparation and pharmaceutical compositions containing them
04/18/2006US7030143 Heterocyclic compounds
04/18/2006US7030141 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
04/18/2006US7030139 Compounds
04/18/2006US7030138 Benzamidine derivatives
04/18/2006US7030125 useful in the treatment of TGF- beta related disease states including, for example, cancer and fibrotic diseases
04/18/2006US7030116 Compounds and compositions as cathepsin inhibitors
04/18/2006US7030115 Anticancer agents; autoimmune diseases; antiinflammatory agents
04/18/2006US7030113 Aminobenzimidazoles as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
04/18/2006US7030110 Cyclic oxyguanidine pyrazinones as protease inhibitors
04/18/2006US7030063 Cyclohexenonquinolinoyl-derivatives as herbicidal agents
04/18/2006US7029835 Photothermographic element comprising improved base precursors and methods for their use
04/13/2006WO2006039243A1 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
04/13/2006WO2006039215A2 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
04/13/2006WO2006039212A2 Substituted 2h-1,3-benzoxazin-4(3h)-ones
04/13/2006WO2006038738A1 Receptor function regulating agent
04/13/2006WO2006038100A1 Oxazolidinone derivatives as antimicrobials
04/13/2006WO2006037481A1 Benzoxazine and quinoxaline derivatives and uses
04/13/2006WO2006037279A1 Recording medium for three dimension operating memory
04/13/2006WO2006031556A3 Amidine substituted aryl aniline compounds
04/13/2006WO2006028958A3 Pyridyl inhibitors of hedgehog signalling
04/13/2006WO2006007540A3 Piperidine derivatives as nk1 antagonists
04/13/2006WO2005116027A3 Indazole and indolone derivatives and their use as pharmaceuticals
04/13/2006WO2005103698A3 Methods and antibodies for nitrofuran detection